%0 Journal Article
%T Unsupervised PrEP in routine practice: a new challenge?
%A Caroline Lions
%A Catherine Tamalet
%A H¨¦l¨¨ne Laroche
%A Isabelle Poizot-Martin
%A Olivia Zaegel-Faucher
%J International Journal of STD & AIDS
%@ 1758-1052
%D 2019
%R 10.1177/0956462419828872
%X Pre-exposure prophylaxis (PrEP) for the prevention of HIV infection with 300 mg daily tenofovir co-formulated with 200 mg emtricitabine is recommended as one prevention option for people who are at substantial risk of acquiring an HIV infection. We report the case of a 28-year-old man who has sex with men and who was referred to our unit for a primary HIV infection with positive p18, p24 and gp160 bands on Western blot analysis but with a low HIV plasma viral load. Although HIV misdiagnosis should always be considered in cases of atypical seroconversion pattern with a low viral burden, unsupervised PrEP should be systematically investigated
%K Prevention
%K human immunodeficiency virus
%K sexual behaviour
%K diagnosis
%K treatment
%U https://journals.sagepub.com/doi/full/10.1177/0956462419828872